A question of capacity
Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more
GPs and consultants have been commenting on the manifestos of the Conservatives and Green Party prior to next month’s Scottish Parliament election.
The Conservatives propose a tariff-based system to reduce patient waiting times.
Dr Charles Saunders, deputy chairman of the BMA’s Scottish Consultants Committee, said: ‘A tariff system would recreate an internal market in the NHS which would in turn, create winners and losers of our local hospitals. Hospitals that lose out on the provision of elective procedures and reduced workload could end up under threat of closure.’
He added that Scotland’s geography heightened concerns that rural units would be unable to compete with urban hospitals.
The Conservatives also plan to review NHS24 and replace it with local, clinician-led units.
Dr Dean Marshall, chairman of the BMA’s Scottish GPC, described the proposal as ‘interesting’, because it would need an increase in the GP workforce.
The BMA has welcomed the Green Party’s proposals to expand preventative medicine and community-based care, including long-term investment for sexual health services, and its plans to tackle smoking and drinking problems in Scotland.
However, the BMA criticised the Green Party’s opposition to fluoridation. Dr Peter Terry, chairman of the BMA in Scotland, said: ‘Scotland has one of the poorest records for dental health in the developed world.’
Other political parties expecting to contest Scottish Parliament seats will release manifestos this week.
Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more
The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more
Working as an educational supervisor can be stimulating and rewarding, says Dr Alexander Williams. Read more
Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more
Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more
Section 1: Epidemiology and aetiology Read more
Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more
Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more
The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more
Comments
Only registered users may comment. Log in now or register for a free account.